Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

Introduction: Neuromyelitis optica (NMO) is a severe demyelinating disease that preferentially involves spinal cord and optic nerve. It is part of a spectrum of neurological conditions associated with antibodies to aquaporin-4 (AQP4). This study investigates the role of MRI where novel, more sensiti...

Полное описание

Библиографические подробности
Главные авторы: Downer, J, Leite, M, Carter, R, Palace, J, Küker, W, Quaghebeur, G
Формат: Journal article
Язык:English
Опубликовано: 2012
_version_ 1826303707677982720
author Downer, J
Leite, M
Carter, R
Palace, J
Küker, W
Quaghebeur, G
author_facet Downer, J
Leite, M
Carter, R
Palace, J
Küker, W
Quaghebeur, G
author_sort Downer, J
collection OXFORD
description Introduction: Neuromyelitis optica (NMO) is a severe demyelinating disease that preferentially involves spinal cord and optic nerve. It is part of a spectrum of neurological conditions associated with antibodies to aquaporin-4 (AQP4). This study investigates the role of MRI where novel, more sensitive AQP4 antibody immunoassay techniques are being used. Methods: Retrospective review of neuroimaging in 69 patients (25 antibody positive, 44 antibody negative), investigated in the context of suspected NMO or NMO spectrum disorder, was performed independently by two consultant neuroradiologists. Results Longitudinally extensive, central spinal cord lesions were more frequent in AQP4 positive patients (95.2% vs 35.5%, p<0.0001; 85.7% vs 45.2%, p=0.015). Multiple sclerosis diagnostic criteria were less frequently fulfilled on brain MRI in antibody positive patients (5.6% vs 33.3%, p=0.035). Juxtacortical and corpus callosal lesions were also less common in this group (16.7% vs 46.7%, p=0.063; 5.6% vs 46.7%, p=0.0034). Hypothalamic and periependymal disease related to the aqueduct was not seen in antibody negative patients. T1 hypointensity was more common in cord lesions of antibody positive patients (75.0% vs 35.3%, p=0.037). However, this characteristic did not discriminate antibody positive and negative longitudinally extensive cord lesions (73.3% vs 62.5%, p=0.66). Conclusion: The NMO spectrum of diseases are among an increasing number of neurological conditions defined by serological tests. However, despite improved immunoassay techniques, MRI of the brain and spinal cord continues to be among the first-line investigations in these patients, providing valuable diagnostic information that will help guide patient management. © Springer-Verlag 2011.
first_indexed 2024-03-07T06:06:48Z
format Journal article
id oxford-uuid:ee21ff3d-d5c6-43bc-a65d-10a6eb8d3037
institution University of Oxford
language English
last_indexed 2024-03-07T06:06:48Z
publishDate 2012
record_format dspace
spelling oxford-uuid:ee21ff3d-d5c6-43bc-a65d-10a6eb8d30372022-03-27T11:30:24ZDiagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ee21ff3d-d5c6-43bc-a65d-10a6eb8d3037EnglishSymplectic Elements at Oxford2012Downer, JLeite, MCarter, RPalace, JKüker, WQuaghebeur, GIntroduction: Neuromyelitis optica (NMO) is a severe demyelinating disease that preferentially involves spinal cord and optic nerve. It is part of a spectrum of neurological conditions associated with antibodies to aquaporin-4 (AQP4). This study investigates the role of MRI where novel, more sensitive AQP4 antibody immunoassay techniques are being used. Methods: Retrospective review of neuroimaging in 69 patients (25 antibody positive, 44 antibody negative), investigated in the context of suspected NMO or NMO spectrum disorder, was performed independently by two consultant neuroradiologists. Results Longitudinally extensive, central spinal cord lesions were more frequent in AQP4 positive patients (95.2% vs 35.5%, p<0.0001; 85.7% vs 45.2%, p=0.015). Multiple sclerosis diagnostic criteria were less frequently fulfilled on brain MRI in antibody positive patients (5.6% vs 33.3%, p=0.035). Juxtacortical and corpus callosal lesions were also less common in this group (16.7% vs 46.7%, p=0.063; 5.6% vs 46.7%, p=0.0034). Hypothalamic and periependymal disease related to the aqueduct was not seen in antibody negative patients. T1 hypointensity was more common in cord lesions of antibody positive patients (75.0% vs 35.3%, p=0.037). However, this characteristic did not discriminate antibody positive and negative longitudinally extensive cord lesions (73.3% vs 62.5%, p=0.66). Conclusion: The NMO spectrum of diseases are among an increasing number of neurological conditions defined by serological tests. However, despite improved immunoassay techniques, MRI of the brain and spinal cord continues to be among the first-line investigations in these patients, providing valuable diagnostic information that will help guide patient management. © Springer-Verlag 2011.
spellingShingle Downer, J
Leite, M
Carter, R
Palace, J
Küker, W
Quaghebeur, G
Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
title Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
title_full Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
title_fullStr Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
title_full_unstemmed Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
title_short Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
title_sort diagnosis of neuromyelitis optica nmo spectrum disorders is mri obsolete
work_keys_str_mv AT downerj diagnosisofneuromyelitisopticanmospectrumdisordersismriobsolete
AT leitem diagnosisofneuromyelitisopticanmospectrumdisordersismriobsolete
AT carterr diagnosisofneuromyelitisopticanmospectrumdisordersismriobsolete
AT palacej diagnosisofneuromyelitisopticanmospectrumdisordersismriobsolete
AT kukerw diagnosisofneuromyelitisopticanmospectrumdisordersismriobsolete
AT quaghebeurg diagnosisofneuromyelitisopticanmospectrumdisordersismriobsolete